Zofran is a prescription antiemetic medicine containing Ondansetron, a selective 5-HT3 receptor antagonistused for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiotherapy, and surgical procedures.
As one of the most widely prescribed antiemetic medications worldwide, Zofran helps improve patient comfort and supports adherence to cancer treatment and postoperative recovery.
Each film-coated tablet contains 4 or 8 mg of ondansetron. One package contains 10 oral tablets.
Active ingredient
Dosage form
Ondansetron selectively blocks 5-HT3 serotonin receptors, preventing activation of the vomiting reflex.
Its therapeutic effects include:
Zofran may be prescribed for:
Dosage is individualized depending on:
Always follow the prescribed dosing schedule.
Potential adverse reactions include:
Seek medical attention if serious side effects occur.
Do not use if you have:
Read the official prescribing information before use.
Store in the original packaging in a dry place at the temperature recommended by the manufacturer. Protect from moisture and direct sunlight.
Zofran is used to prevent and treat nausea and vomiting caused by chemotherapy, radiation therapy, and surgery.
Ondansetron
The antiemetic effect generally begins within 30–60 minutes after oral administration.
Yes. In most countries, it is a prescription-only medication.
Yes, when prescribed by a healthcare professional using age-appropriate dosing.
Yes. It is commonly prescribed to prevent postoperative nausea and vomiting.
Ask a question or inquire about delivery to your country


